🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 159 of 200 · A–Z by INN

  1. rhgm-csf

    NMPA: clinical trials

  2. rhtnk-tpa

    NMPA: clinical trials

  3. ribavirin

    RIBAVIRIN BIOPARTNERS Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn · PMDA: approved

    J05AP01

  4. ribociclib

    KISQALI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01EF02

  5. ribociclib succinate

    KISQALI

    ORAL FDA: approved

  6. riboflavin 5'-phosphate

    PHOTREXA VISCOUS IN DEXTRAN 20%

    OPHTHALMIC FDA: approved

  7. riboflavin 5'-phosphate sodium

    PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

    OPHTHALMIC FDA: approved

  8. ric-conditioning

    NMPA: clinical trials

  9. rifabutin

    MYCOBUTIN Pfizer Australia Pty Ltd

    ORAL FDA: approved · TGA: approved

  10. rifampicin

    RIMYCIN 300 Alphapharm Pty Ltd

    TGA: approved

  11. rifampin

    RIFADIN Teva Pharma GmbH

    INJECTION FDA: approved · NMPA: clinical trials

  12. rifamycin sodium

    AEMCOLO

    ORAL FDA: approved

  13. rifapentine

    PRIFTIN

    ORAL FDA: approved · NMPA: clinical trials

  14. rifaximin

    XIFAXAN Norgine Pty.

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  15. rilonacept

    RILONACEPT FGK REPRESENTATIVE SERVICE GMBH Regeneron UK Limited

    SINGLE-USE FDA: approved · EMA: application withdrawn

    L04AC04

  16. rilpivirine

    EDURANT Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG05

  17. rilpivirine hydrochloride

    RILPIVIRINE HYDROCHLORIDE

    ORAL FDA: approved

  18. riluzole

    PHARMACOR RILUZOLE Sanofi-aventis Healthcare Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N07XX02

  19. rilzabrutinib

    WAYRILZ

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    Not yet assigned

  20. rimantadine hydrochloride

    RIMANTADINE HYDROCHLORIDE

    ORAL FDA: approved

  21. rimegepant

    VYDURA

    ORAL FDA: approved · EMA: approved

    N02CD06

  22. rimegepant sulfate

    NURTEC ODT

    ORAL FDA: approved

  23. rimexolone

    VEXOL

    OPHTHALMIC FDA: approved

  24. rimonabant

    ZIMULTI

    EMA: withdrawn

    A08AX01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources